Venkatraman Radhakrishnan/stjude.org
Jan 4, 2024, 23:40
Venkatraman Radhakrishnan: CTRT in locally advanced inoperable breast cancer
Venkatraman Radhakrishnan, Professor and Head of the Department of Medical Oncology at the Adyar Cancer Institute, shared on X/Twitter:
“Concurrent chemoradiation (CTRT) is SOC in many cancers. Why not in breast cancer?
We show that CTRT in locally advanced inoperable breast cancer increases operability, increases path CR, no increased toxicity, reduces treatment time.”
For details click here.
Source: Venkatraman Radhakrishnan/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12